fluoxetine and sr141716

fluoxetine has been researched along with sr141716 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Malone, DT; Taylor, DA1
Griebel, G; Scatton, B; Stemmelin, J1
Ben-Shabat, S; Fride, E; Gobshtis, N1
Al-Zaman, Y; Aylwin, S1
Ciccocioppo, R; Cifani, C; Di Francesco, C; Massi, M; Melotto, S; Righetti, C; Tessari, M; Zanoncelli, A1

Reviews

1 review(s) available for fluoxetine and sr141716

ArticleYear
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide

2008

Other Studies

7 other study(ies) available for fluoxetine and sr141716

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats.
    British journal of pharmacology, 1999, Volume: 128, Issue:1

    Topics: Animals; Consciousness; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Dronabinol; Fluoxetine; Male; Microdialysis; Perfusion; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors

1999
Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.
    Biological psychiatry, 2005, Feb-01, Volume: 57, Issue:3

    Topics: Aggression; Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Depression; Diazepam; Dose-Response Relationship, Drug; Electroshock; Emotions; Fluoxetine; Gerbillinae; Immobility Response, Tonic; Male; Maze Learning; Mice; Models, Animal; Neuropsychological Tests; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant

2005
Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness.
    European journal of pharmacology, 2007, Jan-12, Volume: 554, Issue:2-3

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Desipramine; Female; Fluoxetine; Maze Learning; Mice; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Swimming; Time Factors; Weight Gain

2007
Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats.
    Addiction biology, 2009, Volume: 14, Issue:4

    Topics: Adrenocorticotropic Hormone; Animals; Anti-Obesity Agents; Appetite Depressants; Cannabinoids; Conditioning, Operant; Corticosterone; Cues; Cyclobutanes; Environment; Feeding Behavior; Female; Fluoxetine; Fructose; Humans; Hypothalamo-Hypophyseal System; Motivation; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rats; Reproducibility of Results; Rimonabant; Selective Serotonin Reuptake Inhibitors; Topiramate

2009